Atlas Trials

An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients.

Clinical trial NCT00510211 · COMPLETED

Trial details

NCT number
NCT00510211
Sponsor
Eli Lilly and Company
Status
COMPLETED
Study type
OBSERVATIONAL
SchizophreniaBipolar Disorder
Start date
2007-04-01
Enrollment
1131

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.